Work

PS5-06-02: Cdk4/6 inhibitor-induced interstitial lung disease: a rare but severe complication in breast cancer treatment

Year: 2026

Type: article

Study design: Case Report

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps5-06-02

Authors: S. A. Haddad, D. U. Portillo, A. M. Nambiar, M. J. Kim, V. Kaklamani, K. I. Lathrop, R. Pathapati

Institutions: Mays Cancer Center at UT Health San Antonio, The University of Texas at San Antonio Health Science Center, University Health System

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129675062

FWCI:

Cites:

Cited by:

Related to: